Novo Nordisk Pauses 3 Clinical Trials Testing Hemophilia Therapy

On Monday Danish company Novo Nordisk announced it would stop treating patients enrolled in clinical trials evaluating an investigational hemophilia drug it developed after three of those receiving the drug reported “thrombotic events.”